Clinical trials
Phase 1/2 trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
| Completed | 15 |
| Terminated | 9 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Trials Ireland | 5 |
| Princess Maxima Center for Pediatric Oncology | 3 |
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| University College Dublin | 2 |
| University of Dublin, Trinity College | 2 |
| Abbott | 1 |
| AlgiPharma AS | 1 |
| Alimentary Health Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 4 |
| Recurrence | 4 |
| Uterine Cervical Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Leukemia | 3 |
| Neoplasm Metastasis | 3 |
| Ovarian Neoplasms | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.